abstract |
Disclosed is a compound of formula III or a pharmaceutically acceptable salt or solvate thereof wherein the substituents are as described in the specification. Also disclosed is the use of the above compound, optionally combined with an anti-cancer agent, for the manufacture of a medicament for treating one or more diseases associated with cyclin dependent kinase. |